Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
2008
2009
2010
Announcements
Articles
Articles and Publications
Campaign
Case Studies
Charge Capture and Pricing
Coding Integrity
Company
Craneware Insights Articles
Directors
Education
Home
Journey
Opportunities
Other
post
Press Releases
Products
Testimonial
Trade Shows
Uncategorized
Upcoming Events
Webinars
White Papers

Grant of Options

13 September 2016 – The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 12 September 2016, the Remuneration Committee approved the granting of share options to certain Directors to subscribe for ordinary shares of 1p each in the Company as follows:

Director No. of options granted Percentage of issued share capital
Keith Neilson (CEO) 28,628 0.14

 
The above options have been granted at an exercise price of 1177.5p per share (being the closing market price on 12 September 2016). These options will be subject to performance criteria, such that they vest in three equal tranches over three years. One third of the share options will vest on or after 30 June 2017, one third on or after 30 June 2018 and the final third on or after 30 June 2019. The share options will not become exercisable until three years from the date of the grant.

For further information, please contact:

Craneware plc

Peel Hunt

  • +44 (0)20 7418 8900
  • Dan Webster
  • Adrian Trimmings
  • George Sellar

Alma

  • +44 (0)208 004 4218
  • Caroline Forde
  • Hilary Forde
  • Robyn McConnachie

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated value cycle solutions that help US provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.